The efficacy of low-dose warfarin initiation (3 mg versus 5 mg) in newly diagnosed venous thromboembolism patients among a population with a high prevalence of warfarin-sensitive haplotype of the VKORC1 gene: a randomized controlled trial

Autor: Bundarika Suwanawiboon, Wannaphorn Rotchanapanya, Komkrit Mahaprom, Wanna Thongnoppakhun, Yupaporn Lalerd, Chanin Limwongse, Nuttawut Sermsathanasawadi, Weerapat Owattanapanich

Publikováno v: Hematology, Vol 27, Iss 1, Pp 95-104 (2022)

Objectives The fact that a lower warfarin maintenance dose is required by Asian populations is well-known. Currently, the American College of Chest Physicians recommends commencing warfarin at a dose between 5 and 10 mg for venous thromboembolism (VT

Externí odkaz: https://doaj.org/article/fb1c69c2867f4951adf11ededf7c3531

Predictive Factors for Survival Outcomes of High-Risk Febrile Neutropenic Patients: a 3-Year Study at a Single Center in Thailand

Autor: Wannaphorn Rotchanapanya, Weerapat Owattanapanich, Nonlawan Chueamuangphan

Publikováno v: Siriraj Medical Journal, Vol 71, Iss 5, Pp 339-348 (2019)

Objective: This study aimed to identify the risk factors associated with mortality in febrile neutropenic patients. Methods: This 3-year, single center, retrospective, observational study was conducted at Chiangrai Prachanukroh Hospital, Chiangrai Pr

Externí odkaz: https://doaj.org/article/d97c342f48fb44ce80c4e068bd407411

Effectiveness of monthly low dose emicizumab prophylaxis without 4-week loading doses among patients with haemophilia A with and without inhibitors: A case series report

Autor: Ampaiwan Chuansumrit, Nongnuch Sirachainan, Suphaneewan Jaovisidha, Tachit Jiravichitchai, Praguywan Kadegasem, Ketsuda Kempka, Monratta Panuwannakorn, Wannaphorn Rotchanapanya, Thunyakorn Nuntiyakul

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d8d04b2f647d40fe8f6555ca6a4733f
https://pubmed.ncbi.nlm.nih.gov/36446746

Precursor B-cell acute lymphoblastic leukaemia-a global view

Autor: Andrea Biondi, Valentino Conter, Mammen Chandy, Primus Ewald, Marie Lucia de Martino Lee, Vivek S. Radhakrishnan, Wannaphorn Rotchanapanya, Patricia Scanlan, Owen Patrick Smith, Boubacar Togo, Peter Hokland

Publikováno v: Biondi, A, Conter, V, Chandy, M, Ewald, P, Lucia de Martino Lee, M, Radhakrishnan, V S, Rotchanapanya, W, Scanlan, P, Patrick Smith, O, Togo, B & Hokland, P 2022, ' Precursor B-cell acute lymphoblastic leukaemia-a global view ', British Journal of Haematology, vol. 196, no. 3, pp. 530-547 . https://doi.org/10.1111/bjh.17959

As haematologists, we always seek to follow standardised guidelines for practice and apply the best treatment within our means for our patients with blood diseases. However, treatment can never follow an exact recipe. Opinions differ as to the best a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e3b1d45ad710e1ff5435d26352fe66
https://pure.au.dk/portal/da/publications/precursor-bcell-acute-lymphoblastic-leukaemiaa-global-view(315d6b69-51a7-45ad-8cd1-7c4b1f168d79).html

Validation in Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring RUNX1 Mutation: A Cohort Study and Meta-Analysis

Autor: Tarinee Rungjirajittranon, Theerapat Siriwannangkul, Nattawut Leelakanok, Smith Kungwankiattichai, Wannaphorn Rotchanapanya, Pongthep Vittayawacharin, Benjamaporn Mekrakseree, Kamolchanok Kulchutisin, Weerapat Owattanapanich

Publikováno v: Blood. 140:3222-3222

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bcb068f973d936f09fc8411052761115
https://doi.org/10.1182/blood-2022-157137